Schizophrenia is a poorly understood illness, but scientists now have greater insight into one of the disorder’s hallmarks, auditory hallucinations, thanks to new research published Thursday.

Sept. 27, 2024 – In a breakthrough for people living with schizophrenia, the FDA has approved a new oral medication for adults. Unlike traditional antipsychotic drugs, the medication ...

No new treatments for schizophrenia have been approved in nearly three decades, but that changed on Sept. 26, when the U.S. Food and Drug Administration (FDA) approved Cobenfy for the psychiatric ...

The U.S. Food and Drug Administration (FDA) approved a novel antipsychotic schizophrenia drug late Thursday, marking the first new treatment in decades for the mental health condition that affects ...

The U.S. Food and Drug Administration has approved a new drug for schizophrenia with a new mechanism of action for the first time in over 70 years. The treatment offers hope to thousands of ...

The FDA has approved the first new class of schizophrenia drug in 70 years Australian ... it that the whole of Victorian society actually made those experiments possible because of their ...

Pallandi concluded at the time of the aggravated assault, Sequeira was suffering from substance use disorder and schizophrenia. The psychiatrist said there are suggestions that paranoia may have ...

Marathi directors, storytellers, and musicians have made significant contributions to Bollywood over the years, infusing the industry with fresh perspectives, rich storytelling, and unique musical ...

The dopamine hypothesis of schizophrenia is a scientific theory that suggests dopamine directly contributes to schizophrenia symptoms. Research on this theory and other causes of schizophrenia is ...

Schizophrenia, a severe psychiatric disorder affecting about 1% of the population, has long been known to have both genetic and environmental roots. Recent years have seen explosive growth in our ...

Neurocrine Biosciences’ schizophrenia program pivot has failed. The biotech was unable to replicate the cognition signal it saw in an earlier midphase study, prompting it to stop development of ...